お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
デフォルト表紙
市場調査レポート
商品コード
1005064

スピルリナ市場調査レポート:タイプ別(アルトロスピラ属マキシマ、アルトロスピラ属プラテンシス)、調製別(顆粒・ゲル化剤、液体、粉末、錠剤・カプセル)、用途別-2026年までの予測-COVID-19の累積的影響

Spirulina Market Research Report by Type, by Drug Formulation, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=112.06円
スピルリナ市場調査レポート:タイプ別(アルトロスピラ属マキシマ、アルトロスピラ属プラテンシス)、調製別(顆粒・ゲル化剤、液体、粉末、錠剤・カプセル)、用途別-2026年までの予測-COVID-19の累積的影響
出版日: 2021年06月01日
発行: 360iResearch LLP
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のスピルリナの市場規模は、2020年の3億1,437万米ドルから、2025年末までに4億3,559万米ドルに拡大すると予測されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。アップデートされた調査では、COVID-19が市場に及ぼす影響を考慮し、洞察、分析、予測などを提供しています。

当レポートでは、スピルリナ市場について調査し、市場の概要とともに、タイプ別、調製別、用途別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 用途別見通し
  • タイプ別見通し
  • 調製別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界のスピルリナ市場、タイプ別

  • アルトロスピラ属マキシマ
  • アルトロスピラ属プラテンシス

第7章 世界のスピルリナ市場、調製別

  • 顆粒&ゲル化剤
  • 液体
  • 粉末
  • 錠剤・カプセル

第8章 世界のスピルリナ市場、用途別

  • 動物飼料
  • 化粧品
  • 食品および飲料
  • 栄養補助食品

第9章 南北アメリカのスピルリナ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域のスピルリナ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカのスピルリナ市場

  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合他社のSWOT分析
  • 競合シナリオ
    • 合併と買収
    • 契約、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • Algenol Biofuels Inc.
  • Chr. Hansen Holding A/S
  • Cyanotech Corporation
  • DDW The Color House
  • DIC Corporation
  • Fuqing King Dnarmsa Spirulina Co. Ltd
  • Naturex S.A
  • Parry Neutraceuticals
  • Sensient Technologies Corporation
  • Sunrise Nutrachem Group Co. Ltd.

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格
図表

LIST OF FIGURES

  • FIGURE 1. GLOBAL SPIRULINA MARKET SIZE, 2020 VS 2026 (USD MILLION)
  • FIGURE 2. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2020 (USD MILLION)
  • FIGURE 3. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2020 (USD MILLION)
  • FIGURE 4. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL SPIRULINA MARKET: MARKET DYNAMICS
  • FIGURE 7. GLOBAL SPIRULINA MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 8. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2020 VS 2026 (%)
  • FIGURE 9. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2020 VS 2026 (USD MILLION)
  • FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2026
  • FIGURE 11. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, 2018-2026 (USD MILLION)
  • FIGURE 12. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 13. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, 2018-2026 (USD MILLION)
  • FIGURE 14. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 15. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2020 VS 2026 (%)
  • FIGURE 16. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2026
  • FIGURE 18. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, 2018-2026 (USD MILLION)
  • FIGURE 19. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 20. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, 2018-2026 (USD MILLION)
  • FIGURE 21. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 22. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, 2018-2026 (USD MILLION)
  • FIGURE 23. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 24. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, 2018-2026 (USD MILLION)
  • FIGURE 25. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 26. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
  • FIGURE 27. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
  • FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2026
  • FIGURE 29. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, 2018-2026 (USD MILLION)
  • FIGURE 30. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 31. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, 2018-2026 (USD MILLION)
  • FIGURE 32. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 33. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, 2018-2026 (USD MILLION)
  • FIGURE 34. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 35. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, 2018-2026 (USD MILLION)
  • FIGURE 36. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 37. AMERICAS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 38. AMERICAS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 40. ARGENTINA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 41. BRAZIL SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 42. CANADA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 43. MEXICO SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 44. UNITED STATES SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 45. CALIFORNIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 46. FLORIDA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 47. ILLINOIS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 48. NEW YORK SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 49. OHIO SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 50. PENNSYLVANIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 51. TEXAS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 52. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 53. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 54. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 55. CHINA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 56. INDIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 57. INDONESIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 58. JAPAN SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 59. MALAYSIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 60. PHILIPPINES SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 61. SOUTH KOREA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 62. THAILAND SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 63. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (%)
  • FIGURE 64. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2020 VS 2026 (USD MILLION)
  • FIGURE 65. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2026
  • FIGURE 66. FRANCE SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 67. GERMANY SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 68. ITALY SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 69. NETHERLANDS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 70. QATAR SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 71. RUSSIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 72. SAUDI ARABIA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 73. SOUTH AFRICA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 74. SPAIN SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 75. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 76. UNITED KINGDOM SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD MILLION)
  • FIGURE 77. GLOBAL SPIRULINA MARKET: FPNV POSITIONING MATRIX
  • FIGURE 78. GLOBAL SPIRULINA MARKET: SHARE, BY QUADRANT, 2020
  • FIGURE 79. GLOBAL SPIRULINA MARKET: SHARE, BY COMPANY, 2020
  • FIGURE 80. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL SPIRULINA MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL SPIRULINA MARKET: MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. AMERICAS SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. AMERICAS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. AMERICAS SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. AMERICAS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. ARGENTINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. ARGENTINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. ARGENTINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. BRAZIL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. BRAZIL SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. BRAZIL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. CANADA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. CANADA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. CANADA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. MEXICO SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. MEXICO SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. MEXICO SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. UNITED STATES SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. UNITED STATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. UNITED STATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. UNITED STATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. CALIFORNIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. CALIFORNIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. CALIFORNIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. FLORIDA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. FLORIDA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. FLORIDA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ILLINOIS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ILLINOIS SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. ILLINOIS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. NEW YORK SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. NEW YORK SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. NEW YORK SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. OHIO SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. OHIO SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. OHIO SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. PENNSYLVANIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. PENNSYLVANIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. PENNSYLVANIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. TEXAS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. TEXAS SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. TEXAS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. CHINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. CHINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. CHINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. INDIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. INDIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. INDIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. INDONESIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. INDONESIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. INDONESIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. JAPAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. JAPAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. JAPAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. MALAYSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. MALAYSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. MALAYSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. PHILIPPINES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. PHILIPPINES SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. PHILIPPINES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. SOUTH KOREA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. SOUTH KOREA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. SOUTH KOREA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. THAILAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. THAILAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. THAILAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY GEOGRAPHY, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. FRANCE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. FRANCE SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. FRANCE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. GERMANY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. GERMANY SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. GERMANY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. ITALY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. ITALY SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. ITALY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. NETHERLANDS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. NETHERLANDS SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. NETHERLANDS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. QATAR SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. QATAR SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. QATAR SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. RUSSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. RUSSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. RUSSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. SAUDI ARABIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. SAUDI ARABIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 109. SAUDI ARABIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 110. SOUTH AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 111. SOUTH AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 112. SOUTH AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 113. SPAIN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 114. SPAIN SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 115. SPAIN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 116. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 117. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 118. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 119. UNITED KINGDOM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 120. UNITED KINGDOM SPIRULINA MARKET SIZE, BY TYPE, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 121. UNITED KINGDOM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2026 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 122. GLOBAL SPIRULINA MARKET: SCORES
  • TABLE 123. GLOBAL SPIRULINA MARKET: BUSINESS STRATEGY
  • TABLE 124. GLOBAL SPIRULINA MARKET: PRODUCT SATISFACTION
  • TABLE 125. GLOBAL SPIRULINA MARKET: RANKING
  • TABLE 126. GLOBAL SPIRULINA MARKET: SHARE, BY QUADRANT, 2020
  • TABLE 127. GLOBAL SPIRULINA MARKET: SHARE, BY COMPANY, 2020
  • TABLE 128. GLOBAL SPIRULINA MARKET: MERGER & ACQUISITION
  • TABLE 129. GLOBAL SPIRULINA MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 130. GLOBAL SPIRULINA MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 131. GLOBAL SPIRULINA MARKET: INVESTMENT & FUNDING
  • TABLE 132. GLOBAL SPIRULINA MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 133. GLOBAL SPIRULINA MARKET: LICENSE & PRICING
  • TABLE 134. GLOBAL SPIRULINA MARKET: CONTACT DETAILS
目次
Product Code: MRR-030EC642E04E

The Global Spirulina Market size was estimated at USD 314.37 Million in 2020 and expected to reach USD 337.13 Million in 2021, at a Compound Annual Growth Rate (CAGR) 7.57% to reach USD 487.29 Million by 2026.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Spirulina to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the Spirulina Market was studied across Arthrospira Maxima and Arthrospira Platensis.

Based on Drug Formulation, the Spirulina Market was studied across Granule & Gelling Agent, Liquid, Powder, and Tablet & Capsule.

Based on Application, the Spirulina Market was studied across Animal Feed, Cosmetics, Food & Beverages, and Nutraceuticals.

Based on Geography, the Spirulina Market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific is further studied across China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Spirulina Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Spirulina Market, including Algenol Biofuels Inc., Australian Spirulina, Cabassi & Giuriati SpA, Chr. Hansen Holding A/S, Cyanotech Corporation, Cyanotech Corporation, DDW The Color House, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd, DOHLER GmbH, Earthrise Nutritionals, LLC, Fuqing King Dnarmsa Spirulina Co. Ltd, GNC Holdings, Inc., GNT Holding B.V., Inner Mongolia Rejuve Biotech Co. Ltd., Naturex S.A, Now Health Group Inc., Parry Nutraceuticals Limited, Pond Technologies Inc., Sensient Technologies Corporation, Sunrise Nutrachem Group Co. Ltd., and Yunnan Green A Biological Project Co., Ltd..

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Spirulina Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Spirulina Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Spirulina Market?
  • 4. What is the competitive strategic window for opportunities in the Global Spirulina Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Spirulina Market?
  • 6. What is the market share of the leading vendors in the Global Spirulina Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Spirulina Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Application Outlook
  • 3.4. Type Outlook
  • 3.5. Drug Formulation Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Awareness of natural health benefits of spirulina superfood
      • 5.1.1.2. Introduction of new varieties of natural food colors produced from spirulina
      • 5.1.1.3. High demand for cyanobacteria for weight reduction and personal care
    • 5.1.2. Restraints
      • 5.1.2.1. Risk of side effects
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for increasing the production of spirulina
      • 5.1.3.2. Importance of Spirulina in cancer treatment
    • 5.1.4. Challenges
      • 5.1.4.1. High cost of spirulina
  • 5.2. Cumulative Impact of COVID-19
  • 5.3. Porters Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry

6. Spirulina Market, by Type

  • 6.1. Introduction
  • 6.2. Arthrospira Maxima
  • 6.3. Arthrospira Platensis

7. Spirulina Market, by Drug Formulation

  • 7.1. Introduction
  • 7.2. Granule & Gelling Agent
  • 7.3. Liquid
  • 7.4. Powder
  • 7.5. Tablet & Capsule

8. Spirulina Market, by Application

  • 8.1. Introduction
  • 8.2. Animal Feed
  • 8.3. Cosmetics
  • 8.4. Food & Beverages
  • 8.5. Nutraceuticals

9. Americas Spirulina Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States
    • 9.6.1. California
    • 9.6.2. Florida
    • 9.6.3. Illinois
    • 9.6.4. New York
    • 9.6.5. Ohio
    • 9.6.6. Pennsylvania
    • 9.6.7. Texas

10. Asia-Pacific Spirulina Market

  • 10.1. Introduction
  • 10.2. China
  • 10.3. India
  • 10.4. Indonesia
  • 10.5. Japan
  • 10.6. Malaysia
  • 10.7. Philippines
  • 10.8. South Korea
  • 10.9. Thailand

11. Europe, Middle East & Africa Spirulina Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis, By Quadrant
  • 12.4. Market Share Analysis, By Company
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. Algenol Biofuels Inc.
  • 13.2. Australian Spirulina
  • 13.3. Cabassi & Giuriati SpA
  • 13.4. Chr. Hansen Holding A/S
  • 13.5. Cyanotech Corporation
  • 13.6. Cyanotech Corporation
  • 13.7. DDW The Color House
  • 13.8. DIC Corporation
  • 13.9. Dongtai City Spirulina Bio-engineering Co., Ltd
  • 13.10. DOHLER GmbH
  • 13.11. Earthrise Nutritionals, LLC
  • 13.12. Fuqing King Dnarmsa Spirulina Co. Ltd
  • 13.13. GNC Holdings, Inc.
  • 13.14. GNT Holding B.V.
  • 13.15. Inner Mongolia Rejuve Biotech Co. Ltd.
  • 13.16. Naturex S.A
  • 13.17. Now Health Group Inc.
  • 13.18. Parry Nutraceuticals Limited
  • 13.19. Pond Technologies Inc.
  • 13.20. Sensient Technologies Corporation
  • 13.21. Sunrise Nutrachem Group Co. Ltd.
  • 13.22. Yunnan Green A Biological Project Co., Ltd.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
  • 14.3. Contact Details
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.